Real-world utilization of biosimilar and originator infliximab in a cohort of patients with inflammatory bowel disease in Turkey

For a full text PDF please complete the form below and we will be in contact shortly! For requests or questions submit the form below: Select Your Country Select CountryAfghanistanAland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua And...